Company Name: Shire Plc.    

Shire Plc. is a biopharmaceutical company. The company develops and markets medicines designed to treat rare diseases and other specialty conditions and has a variety of marketed products and developmental product candidates. The company’s areas of focus include:

  • Gastrointestinal: Including marketed treatments for chronic constipation in women and ulcerative colitis
  • Neuroscience: Including marketed treatments for ADHD and epilepsy
  • Rare Diseases: Including marketed treatments for Fabry disease, Gaucher disease, hereditary angioedema (HAE) and Hunter Syndrome
  • Other Therapeutic Areas: Including marketed treatments for adrenal insufficiency in adults, essential thrombocythemia and hyperphosphatemia in end stage renal disease
  • Developmental pipeline: Includes products candidates for gastrointestinal, hematology, neuroscience, rare diseases and ophthalmics

Ticker Symbol: SHPG (NASDAQ)

Company Website:

Social Media:

Shire LinkedIn

Shire Twitter

Shire YouTube

Headquarters: Dublin, Ireland